These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 17355819
21. Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice. Wang Y, Ebermann L, Sterner-Kock A, Wika S, Schultheiss HP, Dörner A, Walther T. Exp Physiol; 2009 Feb; 94(2):220-7. PubMed ID: 18945756 [Abstract] [Full Text] [Related]
22. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy. Zhang Y, Edgley AJ, Cox AJ, Powell AK, Wang B, Kompa AR, Stapleton DI, Zammit SC, Williams SJ, Krum H, Gilbert RE, Kelly DJ. Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655 [Abstract] [Full Text] [Related]
23. Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats. Krishna KM, Annapurna A, Gopal GS, Chalam CR, Madan K, Kumar VK, Prakash GJ. Can J Physiol Pharmacol; 2005 Apr; 83(4):343-55. PubMed ID: 15877109 [Abstract] [Full Text] [Related]
24. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats. Adewole SO, Ojewole JA. Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509 [Abstract] [Full Text] [Related]
25. Changes in sodium concentration in cardiac myocytes from diabetic rats. Warley A. Scanning Microsc; 1991 Mar; 5(1):239-44; discussion 244-5. PubMed ID: 1828909 [Abstract] [Full Text] [Related]
26. Increased oxysterol contents in diabetic rat hearts: their involvement in diabetic cardiomyopathy. Matsui H, Okumura K, Mukawa H, Hibino M, Toki Y, Ito T. Can J Cardiol; 1997 Apr; 13(4):373-9. PubMed ID: 9141969 [Abstract] [Full Text] [Related]
27. Activation of genes inducing cell-cycle arrest and of increased DNA repair in the hearts of rats with early streptozotocin-induced diabetes mellitus. Golubnitschaja O, Moenkemann H, Trog DB, Blom HJ, De Vriese AS. Med Sci Monit; 2006 Feb; 12(2):BR68-74. PubMed ID: 16449944 [Abstract] [Full Text] [Related]
28. [Effect of tripterysium glucosides on diabetic cardiomyopathy in rats]. Tang M, Guo Y, Zhou Y, Wu G. Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):740-3. PubMed ID: 19624019 [Abstract] [Full Text] [Related]
29. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats. Soliman H, Craig GP, Nagareddy P, Yuen VG, Lin G, Kumar U, McNeill JH, Macleod KM. Cardiovasc Res; 2008 Jul 15; 79(2):322-30. PubMed ID: 18411229 [Abstract] [Full Text] [Related]
30. Cardiac microtubules are more resistant to chemical depolymerisation in streptozotocin-induced diabetes in the rat. Howarth FC, Qureshi MA, White E, Calaghan SC. Pflugers Arch; 2002 Jun 15; 444(3):432-7. PubMed ID: 12111253 [Abstract] [Full Text] [Related]
31. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Westermann D, Van Linthout S, Dhayat S, Dhayat N, Schmidt A, Noutsias M, Song XY, Spillmann F, Riad A, Schultheiss HP, Tschöpe C. Basic Res Cardiol; 2007 Nov 15; 102(6):500-7. PubMed ID: 17909696 [Abstract] [Full Text] [Related]
32. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP, Tschöpe C. Basic Res Cardiol; 2008 Jul 15; 103(4):319-27. PubMed ID: 18347835 [Abstract] [Full Text] [Related]
33. The myocardial protective effects of puerarin on STZ-induced diabetic rats. Pan ZY, Bao ZS, Wu ZM, Wang XM, Zheng JZ, Shen YL, Zhang XM. Fen Zi Xi Bao Sheng Wu Xue Bao; 2009 Apr 15; 42(2):137-44. PubMed ID: 19537197 [Abstract] [Full Text] [Related]
34. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats. Yu BC, Chang CK, Ou HY, Cheng KC, Cheng JT. Cardiovasc Res; 2008 Oct 01; 80(1):78-87. PubMed ID: 18573863 [Abstract] [Full Text] [Related]
35. Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy. Westermann D, Van Linthout S, Dhayat S, Dhayat N, Escher F, Bücker-Gärtner C, Spillmann F, Noutsias M, Riad A, Schultheiss HP, Tschöpe C. Diabetes; 2007 Jul 01; 56(7):1834-41. PubMed ID: 17473225 [Abstract] [Full Text] [Related]
36. [Establishment of a rat model of diabetic erectile dysfunction]. Cheng Y, Wei AY, Li YG. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr 01; 28(4):564-6. PubMed ID: 18495591 [Abstract] [Full Text] [Related]
37. Altered expression of adenosine receptors in heart of diabetic rat. Grdeń M, Podgórska M, Szutowicz A, Pawełczyk T. J Physiol Pharmacol; 2005 Dec 01; 56(4):587-97. PubMed ID: 16391416 [Abstract] [Full Text] [Related]
38. Early blood pressure-independent cardiac changes in diabetic rats. Landau D, Chayat C, Zucker N, Golomb E, Yagil C, Yagil Y, Segev Y. J Endocrinol; 2008 Apr 01; 197(1):75-83. PubMed ID: 18372234 [Abstract] [Full Text] [Related]
39. The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats. Ebermann L, Spillmann F, Sidiropoulos M, Escher F, Heringer-Walther S, Schultheiss HP, Tschöpe C, Walther T. Eur J Pharmacol; 2008 Aug 20; 590(1-3):276-80. PubMed ID: 18571157 [Abstract] [Full Text] [Related]